Form 4 for PRVA Privia Health Group, Inc.
Accepted 2025-05-02 00:00:00 ET · period of report 2025-04-30 · accession 0001759655-25-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-02 | 2025-04-30+ | PRVA | Mehrotra Parth | CEO, Dir | S - Sale | $23.20 | -32.5K | 436.9K | -7% | -$753.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2025-04-30 | S | D | 15,100 | $23.33 | 454,281 | D | — | — | (F1) The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. |
| 2 | Common | Common Stock, $0.01 par value per share | 2025-05-01 | S | D | 17,365 | $23.08 | 436,916 | D | — | — | (F2) This transaction occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.87 to $23.43 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |